Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alteris Therapeutics Inc.

Division of Celldex Therapeutics Inc.

Latest From Alteris Therapeutics Inc.

Alteris Therapeutics Inc.

While a postdoc at Johns Hopkins University in the mid-1980s, Albert Wong, MD, made a fortuitous discovery that would form the basis of a start-up, Alteris Therapeutics Inc. (formerly Spliceomix Inc.), he eventually co-founded almost fifteen years later. His research-studying genes amplified in brain tumors-led him to investigate one of the better-known targets at the time: the EGF receptor (EGFR).

BioPharmaceutical Research and Development Strategies

Selected Start-Ups (5/03)

In Vivo briefly summarizes the technologies of these recently founded companies: Afmedica Inc., BARRx Inc., Bioline Therapeutics, Deciphera Pharmaceuticals Inc., Resonant Medical Inc. and Spliceomix Inc.

See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Spliceomix Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celldex Therapeutics Inc.
  • Senior Management
  • Albert Wong, MD, CSO
  • Contact Info
  • Alteris Therapeutics Inc.
    Phone: (267) 972-5215
    416 South 10th St.
    Philadelphia, PA 19147